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Abstract: Patient safety and quality of care are fundamental pillars in the health policies of various
governments and international organizations. The purpose of this study is to evaluate nurses’
perceptions on the degree of implementation of a protocol for the standardization of care and to
measure its influence on notification of adverse events related to the administration of medications.
This comparative study used data obtained from questionnaires completed by 180 nurses from
medical and surgical units. Our analyses included analysis of variance and regression models. We
observe that the responses changed unevenly over time in each group, finding significant differences
in all comparisons. The mean response rating was increased at 6 months in the intervention group,
and this level was maintained at 12 months. With the new protocol, a total of 246 adverse events
and 481 incidents without harm was reported. Thus, actions such as the use of protocols and event
notification systems should be implemented to improve quality of care and patient safety.
Keywords: adverse events; protocol; patient safety; quality of care; medications
1. Introduction
Patient safety is one of the highest priorities in the health policies of various gov-
ernments and international organizations [1]. In 2004, the World Health Organization
(WHO) created the Alliance for Patient Safety to promote actions, tools, and recommen-
dations designed to improve patient safety during healthcare administration. Currently,
worldwide, up to four out of ten patients suffer damage in primary and outpatient health
care, of which 80% can be prevented [1]. The most damaging errors are related to the
prescription and use of medications [2,3]. In high-income countries, an estimated one in
ten patients is harmed while receiving hospital care [4]. Similarly, in the 37 countries of the
Organization for Economic Cooperation and Development (OECD), 15% of total hospital
activity and expenditure is a direct result of adverse events (AEs) [4]. Other studies carried
out in Australia and England [2] and in Holland [3] refer to enhancing responsibility and
security and increasing notifications with better training, education, and implementation of
a protocol. In fact, in 2017, the WHO established safety in the administration of medicines
as the next global challenge for patient safety [5].
In Spain, the 2015–2020 Spanish Strategy for Safety and Health at Work was devel-
oped, which recommends improving the culture of safety in health organizations and
incorporating health risk management tools and training professionals in basic aspects
of safety [6], including those related to the prevention of medication errors (MEs). MEs
are difficult to prevent before they reach the patient and can have adverse consequences
both in terms of morbidity and mortality [7–12]; they are the result of a multitude of fac-
tors, including human errors as well as characteristics of the health system or institutions
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themselves, such as the availability of resources, care overload, distractions, anxiety in
professionals, and a lack of standardized protocols for the preparation and administration
of medications [13–15].
The recommendations from the International Alliance of the WHO for Patient Safety and
the National Health System in Spain (2015–2020) [6] were specifically designed to reduce MEs,
including the use of notification systems for improving the “culture of safety in hospitals”
and the implementation of action protocols for the preparation and administration of drugs
in their considerations [16,17]. Protocols support health professionals by describing processes
and interventions, and compliance with them helps reduce errors [18–24].
The objective of this study is to evaluate nurses’ perceptions on the degree of im-
plementation of a protocol for standardization of the preparation and administration of
medications, and its influence on the notification of AEs related to MEs in a General
University Hospital in the Spanish National Health System.
2. Materials and Methods
2.1. Design and Study Subjects
The type of study was quasi-experimental non-randomized, and the study was car-
ried out at the General University Hospital of Elda (Alicante-Spain). The organization
of hospital services is divided into two independent buildings corresponding to medical
units (internal medicine and medical specialties) and surgical units (traumatology and
orthopedics, surgery, and gynecology/obstetrics), a situation that allowed for separation of
the intervention and control groups, respectively. A gradual approach was made toward
the development of a complex intervention: a protocol with the objective of standardizing
and administering the medication prescribed to the patient in conditions of safety and
quality. It was initially implemented in medical units, and during this process, the nursing
professionals in these units received specific training on the protocol during the imple-
mentation process. Participant data were collected at the beginning of the implementation
process and during a 12-month follow-up period. As a comparison group, data were
collected from nurses in surgical units in which implementation of the protocol had not
yet begun. The inclusion criteria in both groups were more than two years of experience
working in the unit and having a current employment contract with more than 12 months
until its expiration. Nurses who explicitly expressed not wanting to participate or did not
sign the informed consent were excluded.
2.2. Protocol Development
During the development of the new protocol, we reviewed the current scientific
literature and national reference documents on drug administration safety. We consulted
the Patient Safety Strategy (2015–2020) [6] and Good Practice Guide for the Preparation of
Medicines (GBPP) [25] from the National Health System, the report on the evolution of the
implementation of safe drug use practices in Spanish hospitals (2007–2011) [26], and the
current protocols in use at different Spanish hospitals [27–29]. The Web of Science, Scopus,
and PubMed databases were consulted to search for academic literature by combining the
following keywords “nursing”, “protocol”, “medication”, and “safety”.
Once the relevant information was located, the protocol used in this study was de-
veloped by using the Delphi methodology to help us reach a consensus among a group
of experts. For the selection of experts, healthcare professionals directly related to man-
agement fields (experts in safety and quality), teaching, research, and healthcare provision
were considered. Thus, we selected 10 expert professionals in advanced-practice nursing
in different fields in order to ensure the plurality of the approaches examined.
The Delphi study was divided into two phases:
• Phase I. In this stage, we consulted the annual report on the notification of adverse
drug events at the Elda hospital [30] and aimed to agree upon the skills that healthcare
nurses require to safely administer medications. This aspect was carried out in two
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rounds of the Delphi process (definition and formation of the group of informants)
with the panel of experts.
• Phase II. This second phase was designed to agree upon the development of each
procedural skill for the safe administration of drugs through the protocol as well as
the type of training required to achieve these respective levels of development. Round
3 included the execution of consultations, and in round 4, the results of the Delphi
process were implemented for this phase.
For the purpose of this research, “consensus” was defined as a minimum of 80%
convergence in the opinions of the experts.
To comply with the ethical standards related to human experimentation, we submitted
our study protocol for consultation and approval by the Nursing Procedures Commission
at the Elda Health Department. The commission comprised 10 nurses who were experts
in the advanced practice of nursing procedures in the hospital setting (who differed from
those participating in the Delphi group). The protocol was approved on 8 March 2018.
2.3. Implementation Process
Up until the development and implementation of the new protocol described in this
article, Elda Hospital followed the guidelines developed for the process of safe adminis-
tration of medicines collected in the Nursing Activities Guide published by the Universal
Ministry of Health and Public Health of the Valencian Community (Conselleria de Sanitat
Universal i Salut Pública de la Comunitat Valenciana; 2011) [31]. The implementation
process of the new protocol was piloted in the hospital’s medical units, while the previous
guidelines were maintained in the surgical and critical care units.
The nurses in the units where the new protocol was applied completed training
sessions prior to the new protocol implementation (intervention group; IG) and were
followed up at 0, 6, and 12 months in order to increase their awareness of the importance
of standardization and of updating the protocols for the safe administration of medicines
procedures. According to these guidelines as well as the standards of safety and quality,
the sessions (1) presented the new protocol, (2) defined its legal framework and current
general guidelines for the procedures applied for the safe administration of drugs, (3)
presented the computer systems used for the notification of AEs, (4) and explained the
concepts of clinical safety. This training was subsequently accredited and recognized by the
Commission for Ongoing Training of Spanish National Health System Health Professionals
in the Valencian Community (Comisión de Formación Continuada de los Profesionales
Sanitarios de la Comunidad Valenciana del Sistema Nacional de Salud de España).
2.4. Variables
We evaluated the nurses’ perceptions on the degree of implementation of the new
protocol, relating it to MEs in the context of notification of AEs. To achieve this, we used the
Safety of the System for the Use of Medicines in Hospitals Self-Assessment Questionnaire,
adapted from the Institute for Safe Medication Practices (ISMP) Medication Safety Self-
Assessment® for Hospitals [32], which was first validated and authorized by the Institute
for Safe Medication Practices (ISMP) in Spain. Thus, considering the patient quality
and safety standards provided in the National Health System Patient Safety Strategy for
the 2015–2020 period, strategic line 2: “Safe clinical practices” [6], and after reaching a
consensus among our research group, we selected 10 questions that reflect the factors we
wanted to address in this current study.
The final questionnaire we used had a Likert-type response scale with 5 options, as
follows: 0, “No efforts have been made to implement this point.”; 1, “This point has been
discussed for possible implementation but has not yet been implemented.”; 2, “This point
has been partially implemented in some or all areas of the institution.”; 3, “This point has
been fully implemented in some areas of the institution.”; and 4, “This point has been
fully implemented throughout the institution.” Thus, the maximum possible score for
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the questionnaire was 40 points, which therefore represented full implementation of all
the practices.
The evaluation was carried out at four different time points: at the starting pre- and
post-intervention phases of the protocol implementation (T0), at 6 months (T6), and at
12 months (T12), and the overall score was calculated as the sum of the scores for the
10 items on the questionnaire. In addition, the following sociodemographic data were
collected for all participants: age, sex, number of years since the completion of their
academic training, and the number of years of experience in the unit in which they worked.
The data regarding the notification of AEs were obtained through the annual report on
the notification of AEs, prepared by the hospital’s risk management working group during
the pre- and post-implementation periods of the new protocol. These data were extracted
through the Adverse Event Notification System (SINEA in its Spanish acronym), which
was created to collect and channel information on patient safety events occurring in the
Valencian Community (Generalitat Valenciana, Conselleria de Sanitat, SINEA, 2013) [30].
2.5. Ethical Considerations
After receiving approval from the Clinical Research Ethics Committee (code ADMED
1.0), we provided the nurses in the medical units with an information sheet about this study
and requested their informed consent to participate. This study complied with the ethical
principles for medical research on human beings established in the Declaration of Helsinki.
The data were considered strictly confidential and were protected from unauthorized use
by anyone other than the study authors. The confidentiality of the participants was also
respected during the data processing and analysis. At all times, the participants were
identified with their own study code so that they all carried the acronym ADMED and
then three numbers in sequence (ADMED001, ADMED002, etc.).
2.6. Data Analysis
We performed a descriptive analysis of all the variables by calculating their frequencies.
Contingency tables were used to analyze the homogeneity of the control group (CG) and
IG, applying Chi-squared tests for the categorical variables and by comparing the mean
values for the quantitative variables using Student t-tests. Linear regression models were
adjusted to the responses at each time point to analyze their association with the covariates
and group factors. A repeated measures analysis of variance procedure was performed to
observe the changes in response over time in each group. The programs used were Excel
for the database and SPSS software (version 25.0; IBM Corp., Armonk, NY, USA), and the
results were considered significant if p < 0.05.
3. Results
A total of 180 nurses participated in this study, with 90 each in the IG and CG. In
relation to the sociodemographic variables, 88.9% were women and 74.4% had attended
the University of Alicante (Spain). The participants had completed their training a mean of
16.09 years prior and had been providing care in their unit for an average of 10.81 years.
The highest mean questionnaire item scores were obtained for questions related
to current protocols (item 1) and the provision of information to patients and relatives
(item 10). The lowest mean scores were obtained for the questions about separated drug
preparation areas (item 4), distractions and noises (item 5), and staffing (item 6). The
average scores increased in the IG between 0 and 6 months and remained stable from 6 to
12 months.
Table 1 shows the means and standard deviations (SDs) for each of the survey ques-
tions in both the CG and IG during different phases of the study.
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Table 1. Means of the questionnaire items in the different phases of the study.
Questions









IG CG IG CG
C1
Mean 0.387 0.389 3.146 0.389 3.244 0.389 3.244 0.416
SD 0.510 0.513 0.441 0.513 0.504 0.513 0.504 0.580
C2
Mean 1.133 1.178 2.567 1.178 2.633 1.178 2.678 1.169
SD 1.212 1.214 0.720 1.214 0.800 1.214 0.846 1.208
C3
Mean 0.956 0.956 2.622 0.956 2.756 0.956 2.811 0.966
SD 1.340 1.340 0.907 1.340 0.987 1.340 1.027 1.344
C4
Mean 1.956 1.900 1.511 1.900 1.511 1.900 1.511 1.888
SD 1.872 1.861 0.877 1.871 0.877 1.861 0.877 1.867
C5
Mean 1.878 1.789 1.511 1.789 1.511 1.800 1.533 1.820
SD 1.895 1.887 0.877 1.887 0.877 1.885 0.889 1.886
C6
Mean 0.156 0.156 1.178 0.156 1.178 0.156 1.178 0.157
SD 0.539 0.539 0.384 0.539 0.384 0.539 0.384 0.541
C7
Mean 1.078 1.111 2.044 1.111 2.044 1.133 2.056 1.157
SD 1.183 1.194 0.686 1.194 0.686 1.201 0.693 1.186
C8
Mean 0.389 0.389 1.956 0.389 1.956 0.444 1.978 0.449
SD 0.490 0.490 0.847 0.490 0.847 0.602 0.861 0.603
C9
Mean 0.556 0.578 1.956 0.578 1.956 0.578 1.989 0.584
SD 0.721 0.734 0.847 0.734 0.847 0.734 0.868 0.736
C10
Mean 2.356 2.367 3.133 2.367 3.222 2.367 3.278 2.393
SD 1.819 1.826 0.545 1.826 0.595 1.826 0.619 1.819
Table 2 shows a comparison of the data by age, years since completion of training,
and years of work experience. No differences were observed between the IG and CG for
any of these variables.
Table 2. Sociodemographic data.
N Mean SD p-Value
Age Control 90 36.59 5.86 0.797Intervention 90 36.82 6.28
Years since training completion Control 90 16.12 6.15 0.942Intervention 90 16.06 6.17
Experience Control 90 10.32 4.2 0.155Intervention 90 11.29 4.87
We observed significant differences in all the comparisons when we analyzed the
mean scores in the questionnaire at the different measurement time points (Table 3).
Figure 1 shows how the responses changed unequally in each group over time. When
the intervention was first implemented (T0), the response distribution was similar in both
groups. However, compared to the CG, the response was greater in the IG at both 6 and
12 months. We observed that the mean scores at each time point did not differ over time
for the CG while the mean response for the IG significantly increased at 6 months and
remained stable between 6 and 12 months.
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Table 3. Difference in the means.
Difference in the Means Error p-Value
Control
T0–6 months −0.089 0.030 <0.012
T0–12 months −0.178 0.043 <0.000
6 months–12 months −0.089 0.030 <0.012
Intervention
T0–6 months −11.178 0.623 <0.000
T0–12 months −11.422 0.637 <0.000
6 months–12 months −0.244 0.053 <0.000
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Figure 1. Response changes ov r time.
Data from the annual report on the notification of AEs indicated that, during use of
the old protocol in 2018, 173 AEs (falls, MEs, allergic drug reactions, and phlebitis) and
210 incidents without harm (misidentification, MEs, peripheral line extravasation, allergic
drug reactions, and falls) were reported while, during the use of the new protocol in 2019,
246 AEs and 481 incidents without harm were reported. As shown in Table 4, the number of
AEs and incidents without harm related to MEs reported before and after implementation
of the new protocol increased from 2018 to 2019.
Table 4. Adverse events and incidents without harm.
Error Type 2018 2019


































Total 173 100 246 100
4. Discussion
The objective of this study was to assess nurses’ perceptions after implementing a
new protocol for the safe administration of medications and to analyze its impact on
systems for reporting AEs. Realization of the protocol and its subsequent implementation
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in the hospital in our study allowed us to reach a consensus for each criteria in each of the
procedures for the safe administration of medications through the Delphi methodology
and to know the type of educational intervention to achieve this level of development. We
emphasize that, in the process of safe administration of medicines, nurses begin participated
from the beginning of the program (prescription, preparation, dispensing, administration,
registration, and evaluation). Our data shows that the number of notifications increased
after implementation of the protocol, perhaps because the safety culture had improved
after completion of the training sessions and protocol execution. Notification depended
not only on awareness of the error but also on the good will of the staff documenting it
and, especially, the climate of trust transmitted by the organization’s leaders. Creating this
climate meant that notifications would be understood as opportunities to improve safety
and not as a mechanism for blame or punishment [3,23,24].
This study addressed a strategy for improving the management of clinical practice
because the use of protocols can help to standardize and simplify the management and
administration of medications [13,16,20,22,33]. Thus, protocolization is one of the most
widely used strategies to reduce both variability in clinical practice and the incidence of
errors in the medication administration process [18,20,34–39].
Complete protocol implementation was reported in the IG healthcare units in terms of
the information received by patients. During the administration of drugs, patients and/or
relatives were not usually informed about the generic and/or commercial name of the
drugs used or their action, doses, or the most prominent possible AEs. The provision of
this information is an essential part of the medication administration process, although we
must emphasize that this function must be carried out with great professional responsibility
and while considering the related medical ethics [40,41].
In contrast, the responses from both groups remained unchanged during the pre- and
post-intervention phases for the questions that referred to distractions and separated areas.
In this sense, medications are often administered in difficult conditions, which can create
opportunities for interruptions and distractions [14,42].
In this study, the lowest scores were obtained in reference to staffing. Here, it is
important to mention the role played by health organizations because it is their responsi-
bility to implement measures and barriers to prevent AEs, especially those with serious
consequences that have already occurred at least once. Past studies that have analyzed the
safety culture of organizations and measured the impact of these protocols have shown
that inadequate involvement and staffing by professionals risks the safety of patients
and reduces the success rates of drug administration quality plans [43]. Thus, the role of
managers and staffing levels in healthcare units is crucial to achieve a positive culture of
safety in healthcare institutions [1].
Regarding the training that nurses had received on medication administration systems
(e.g., infusion pumps, automatic preparation equipment, etc.), partial implementation was
observed in the IG units. Various authors and international organizations advise creating
strategies to change the design of nursing jobs as well as the use of targeted technologies
to reduce errors [44–47]. In this current study, we observed that prior training of the
staff in units where a new protocol for the safe administration of medicines would be
implemented helped to improve and sustain the perception that these professionals had
over time on the degree of implementation and compliance with the protocol as well as
its perceived usefulness. We were unable to find other studies that have analyzed this
question over time.
Limitations and Solutions
Among the main limitations of this research are those inherent to this type of study:
obtaining the sample from a single hospital center and being based on the willingness of
the nurses to participate. The difficulties encountered in a Delphi study are the imposition
of preconceptions on the experts and the techniques of summarizing and presenting the
responses of the coordinating group.
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5. Conclusions
At a practical level, our results indicate, in the IG, nurses’ perceptions on improve-
ments in the degree of implementation of a protocol for the safe administration of medica-
tions. We consider our contributions to be of special interest, since the protocol encourages
safe clinical practices and the non-punitive characteristics of adverse event notification
systems, improving the safety culture. In this way, through our study, we provided a
solution in line with the action strategies proposed by the WHO and different international
organizations to be a global challenge for patient safety.
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